PHARMACY

CVS’ Project Health to deliver more than $21M worth of preventive health screenings

BY Antoinette Alexander

WOONSOCKET, R.I. — CVS/pharmacy announced on Wednesday the launch of Project Health (Proyecto Salud in Spanish), a wellness program delivering more than $21 million worth of free health screenings to multicultural communities.

The program, which aims to prevent disease through early detection, grew from CVS/pharmacy’s To Your Health/A Su Salud campaigns. This year, Project Health will offer an array of free comprehensive health risk assessments and screenings during five disease-specific national health awareness months, from American Heart Month (February) to Diabetes Awareness Month (November). More than 1,000 Project Health events are scheduled for 2012 in Atlanta, Chicago, Dallas-Fort Worth, Detroit, Houston, Los Angeles, Miami, New York, Philadelphia and Washington, D.C. Events are also planned at CVS/pharmacy locations in Puerto Rico.

"We know that for a variety of reasons multicultural populations have difficulty accessing and benefitting from preventive care," saidTroyen Brennan, EVP and chief medical officer at CVS Caremark. "Making this issue even more disconcerting, these same patients disproportionately suffer from certain treatable conditions, like high blood pressure and diabetes. Through Project Health, CVS/pharmacy will work to achieve better health outcomes among multicultural populations and is once again making the commitment to helping people on their path to better health."

Project Health is a part of efforts by CVS/pharmacy to improve access to preventive care and ensure that cost is not a barrier to important services, such as professional health assessments and screenings. Project Health events, while offered to address and raise awareness of ethnic health disparities, are open to everyone and will not require an appointment.

Medical personnel will be on hand to provide diabetes, blood pressure, cholesterol and osteoporosis screenings and examine patients for oral care issues. Referrals for mammograms and pap smears also will be provided, as well as consultations with nurse practitioners and CVS pharmacists. A selection of screenings will be available at each event.

Once screened, CVS/pharmacy will help patients through on-site consultations with bilingual (Spanish/English) nurse practitioners who will analyze the results and refer patients to no-cost or low-cost medical facilities within that neighborhood or to their primary care physician should additional follow-up be required.

In 2011, CVS/pharmacy provided free and low-cost medical screenings and services valued at $150 per person through the To Your Health/A Su Salud programs. More than 162,000 people were screened during last year’s events. Of the individuals screened, many health concerns were discovered, including:

  • 57% had at least one abnormal screening result;

  • 48% had at least one abnormal risk factor for heart disease;

  • 42% had risk factors for osteoporosis; and

  • 27% had abnormal glucose readings.

The Project Health events will be held at designated CVS/pharmacy locations on weekdays from 3 to 7 p.m. daily with no appointment necessary during American Heart Month (February), National Minority Health Month (April), Immunization Awareness Month (August), Dental Hygiene Awareness Month (October) and Diabetes Awareness Month (November).


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Takeda launches Edarbyclor

BY Alaric DeArment

DEERFIELD, Ill. — Takeda Pharmaceutical has launched a drug for treating high blood pressure in adults, the company said.

Takeda announced the availability of Edarbyclor (azilsartan medoxomil and chlorthalidone), a once-daily tablet for the condition, also known as hypertension.

"February is American Hearth Month, and it’s important to recognize that nearly 40% of hypertension patients are not at their blood pressure targets, putting them at increased cardiovascular risk," Takeda Pharmaceuticals U.S.A. president Douglas Cole said. "We’re pleased to bring Edarbyclor to market and expand the Edarbi family of products to help appropriate patients with hypertension work towards reaching their blood pressure goals."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Todd Mitchell appointed president of Crossmark’s U.S. sales agency

BY Allison Cerra

PLANO, Texas — A Crossmark EVP is taking on a new role at the company.

Todd Mitchell, who has worked at Crossmark for more than 12 years, now will serve as president of the company’s U.S. sales agency. Ben Fischer, who served as COO and president of Crossmark’s U.S. sales agency now will solely focus on his COO duties, the company said.

Crossmark’s U.S. operations are divided into a marketing services division and a sales agency division.

“We believe these moves demonstrate our continuing assurance of providing service excellence and our commitment to helping our clients achieve their goals,” Crossmark CEO John Thompson said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?